Get the Stockscreener App
33.31
0.70%
-0.235
Overview
News
Price History
Option Chain
Financials
Why BAX Down?
Discussions
Forecast
Stock Split
Dividend History
Baxter International Inc stock is traded at $33.31, with a volume of 887.87K.
It is down -0.70% in the last 24 hours and down -7.12% over the past month.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter has signed an agreement to sell its kidney care tools by early 2025.
See More
Previous Close:
$33.55
Open:
$33.51
24h Volume:
887.87K
Relative Volume:
0.24
Market Cap:
$17.03B
Revenue:
$17.28B
Net Income/Loss:
$108.00M
P/E Ratio:
6.5324
EPS:
5.1
Net Cash Flow:
$391.00M
1W Performance:
+1.35%
1M Performance:
-7.12%
6M Performance:
-2.24%
1Y Performance:
-8.85%
1-Day Range:
$33.10
$33.58
1-Week Range:
$32.98
$33.81
52-Week Range:
$31.60
$44.01
Baxter International Inc Stock (BAX) Company Profile
Name
Baxter International Inc
Sector
Industry
Phone
(847) 948-2000
Address
ONE BAXTER PKWY, DEERFIELD, IL
Compare BAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
33.33 | 17.03B | 17.28B | 108.00M | 391.00M | 0.20 |
|
ISRG
Intuitive Surgical Inc
|
535.73 | 193.58B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
222.12 | 64.01B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
87.03 | 43.01B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
248.18 | 35.98B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
318.18 | 23.43B | 2.88B | 499.60M | 321.60M | 6.74 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| May-30-24 | Initiated | Goldman | Neutral |
| May-10-24 | Downgrade | TD Cowen | Buy → Hold |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-06-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-03-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-19-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-15-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jun-24-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Goldman | Neutral → Sell |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-18-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-18-22 | Reiterated | Morgan Stanley | Overweight |
| Feb-18-22 | Reiterated | Raymond James | Outperform |
| Feb-18-22 | Reiterated | Stifel | Buy |
| Feb-18-22 | Reiterated | UBS | Neutral |
| Feb-18-22 | Reiterated | Wells Fargo | Overweight |
| Feb-11-22 | Initiated | Goldman | Neutral |
| Jan-07-22 | Resumed | Citigroup | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-13-21 | Upgrade | Cowen | Market Perform → Outperform |
| Sep-03-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-06-21 | Downgrade | UBS | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Oct-01-20 | Upgrade | Citigroup | Neutral → Buy |
| Sep-04-20 | Downgrade | Argus | Buy → Hold |
| Jun-24-20 | Initiated | Oppenheimer | Outperform |
| Mar-19-20 | Upgrade | Stifel | Hold → Buy |
| Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-02-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-17-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-26-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Apr-08-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-02-19 | Upgrade | Citigroup | Neutral → Buy |
| Jan-02-19 | Upgrade | Morgan Stanley | Underweight → Overweight |
| Nov-02-18 | Upgrade | Argus | Hold → Buy |
| Oct-16-18 | Initiated | Barclays | Underweight |
| May-17-18 | Resumed | Piper Jaffray | Overweight |
| Feb-06-18 | Reiterated | Citigroup | Neutral |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Jan-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
View All
Baxter International Inc Stock (BAX) Latest News
Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL
FDA labels Baxter’s haemodialysis machine recall Class I - Medical Device Network
Baxter International (WBO:BAX) Shares Outstanding (EOP) : 510 Mil (As of Sep. 2024) - GuruFocus.com
Baxter IV fluid manufacturer says more than 1,000 employees are back at McDowell County plant - McDowell News
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter Wins AMCHAM Awards for Sustainability in Dialysis - Bangkok Post
Ex-Dividend Reminder: Perrigo, Baxter International and National Bank Holdings - Nasdaq
Baxter International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Chronic Wound Care Market to Expand at a Modest 4.17% CAGR through 2031 | SkyQuest Technology - Benzinga
BAX (Baxter International) Total Inventories : $2,103 Mil (As of Sep. 2024) - GuruFocus.com
BAX (Baxter International) 5-Year EBITDA Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
Immunoglobulins Global Market Report 2024 To 2033 | Baxter - openPR
Baxter International (MIL:1BAX) Free Cash Flow : €355 Mil (TTM As of Sep. 2024) - GuruFocus.com
Baxter International Inc. (NYSE:BAX) Receives $40.91 Average Price Target from Brokerages - MarketBeat
Baxter International Inc. Announces Resignation of Peter M. Wilver as Board of Directors, and the Audit Committee and Compensation and Human Capital Committee, Effective December 31, 2024 - Marketscreener.com
Baxter announces board changes, new audit chair By Investing.com - Investing.com South Africa
Baxter International (BAX) Announces Board Changes with Resignat - GuruFocus.com
Baxter announces board changes, new audit chair - Investing.com
Baxter International Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Baxter International Announces Board Changes for 2024 - TipRanks
IV fluid shortage after hurricane hit Baxter International plant prompts hospitals to conserve - Chicago Sun-Times
Debbie Wasserman Schultz of Florida's 25th district makes notable trades in Baxter International and New Gold Inc. - Investing.com Nigeria
Rep. Debbie Wasserman Schultz Purchases Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International releases first IV product after Helene - WCNC.com
Baxter International Inc. (NYSE:BAX) Shares Sold by Thompson Siegel & Walmsley LLC - MarketBeat
Mountain Home’s Baxter Lab to divide as part of $3.8B global deal - Mountain Home Observer
Biosurgery Market Size, Share Projections 2031 by Key - openPR
Baxter International Stock: Analyst Estimates & Ratings - MSN
Baxter's Moat Still Narrow, Despite Recent Bad Capital Allocation Decisions - Morningstar
Oneview Healthcare Expands Baxter Partnership and Reports Financial Growth - MSN
Baxter International (BAX) Beats Q3 Earnings Estimates - MSN
Baxter International Inc. stock outperforms competitors despite losses on the day - MarketWatch
Baxter to Present at 7th Annual Evercore HealthCONx Conference - Marketscreener.com
Nationwide IV fluid shortage changing how hospitals manage patient hydration : ShotsHealth News - NPR
Baxter International facility resumes IV and PD fluid manufacturing post-Helene - WLOS
Baxter International providing updates on recovery efforts after Helene - WCNC.com
Baxter International Inc. (NYSE:BAX) Shares Sold by Cincinnati Financial Corp - MarketBeat
Baxter - EV Magazine
Baxter International Inc Stock (BAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):